Is Agios Pharmaceuticals, Inc. AGIO stock halal to invest in?

No, as of February 2026, Agios Pharmaceuticals, Inc. stock (AGIO) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Agios Pharmaceuticals, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Agios Pharmaceuticals, Inc. and alternative halal stock options within the Tabadulat app.

How often is Agios Pharmaceuticals, Inc. AGIO reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Agios Pharmaceuticals, Inc. AGIO monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Agios Pharmaceuticals, Inc. AGIO pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Agios Pharmaceuticals, Inc. stock (AGIO) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Agios Pharmaceuticals, Inc. AGIO pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Agios Pharmaceuticals, Inc. stock (AGIO) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Agios Pharmaceuticals, Inc. stock (AGIO) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Agios Pharmaceuticals, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

AGIO

About

Agios Pharmaceuticals, Inc.

AGIO

Agios Pharmaceuticals Inc. is a biopharmaceutical company dedicated to pioneering the development of innovative therapies for genetically defined diseases. The core focus of Agios is to leverage the science of cellular metabolism to develop transformative treatments for patients. Key areas of impact include hematological malignancies and rare genetic diseases, where the company has made significant strides in understanding and targeting the metabolic pathways that drive disease. Agios Pharmaceuticals conducts extensive research to identify and advance drug candidates, optimizing their potential impact on improving patient outcomes. Founded in 2008 and headquartered in Cambridge, Massachusetts, the company operates within the burgeoning biotech and healthcare sectors, contributing to revolutionary advances in medical treatments. Agios’ commitment to research excellence and its focus on unmet medical needs underscore its significance in the biotechnology market, positioning it as a notable player in the field of next-generation therapeutic development.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

486

Website:

https://www.agios.com

AGIO

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Agios Pharmaceuticals, Inc.

About

Agios Pharmaceuticals, Inc.

AGIO

Frequently asked questions

Is Agios Pharmaceuticals, Inc. AGIO stock halal to invest in?

How often is Agios Pharmaceuticals, Inc. AGIO reviewed for Shariah compliance?

Does Agios Pharmaceuticals, Inc. AGIO pass the AAOIFI Non Permissible Income criteria?

Does Agios Pharmaceuticals, Inc. AGIO pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Agios Pharmaceuticals, Inc. AGIO stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.